About: covid:PMC7401467

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC7401467 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
Creator	Cassin, Ramona Noto, Alessandro Reda, Gianluigi Farina, Lucia Ghia, Paolo Scarfò, Lydia Borella, Chiara Molteni, Alfredo Montillo, Marco Tedeschi, Alessandra Zamprogna, Giulia
is schema:about of	named entity 'Hospital' named entity 'hematological' named entity 'COVID-19' named entity 'hypertension' named entity 'SARS-CoV-2' named entity 'CD8' named entity 'CLL' named entity 'CLL' named entity 'CLL' named entity 'humoral' named entity 'Th17 cells' named entity 'B-cell' named entity 'COVID-19 infection' named entity 'COVID' named entity 'CLL' named entity 'rituximab' named entity 'cytokine release syndrome' named entity 'SARS-CoV-2' named entity 'COVID' named entity 'cell-mediated immunity' named entity '2, 3' named entity 'ibrutinib' named entity 'COVID' named entity 'CD4' named entity 'Hematology' named entity 'chemoimmunotherapy' named entity 'ibrutinib' named entity 'infectious disease' named entity 'pulmonary embolism' named entity 'pneumonia' named entity 'ibrutinib' named entity 'Lombardy' named entity 'Th1/Th2' named entity 'comorbidities' named entity 'monocytes' named entity 'ibrutinib' named entity 'B-cell' named entity 'interstitial pneumonia' named entity 'mortality rates' named entity 'macrophages' named entity 'hematological malignancies' named entity 'clinical trials' named entity 'Btk' named entity 'small molecules' named entity 'CLL' named entity 'cough' named entity 'alveolar' named entity 'evolution' named entity 'cell-mediated' named entity 'Th1' named entity 'ibrutinib' named entity 'Italian' named entity 'fever' named entity 'fludarabine' named entity 'comorbidities' named entity 'irreversible inhibitor' named entity 'CD4' named entity 'COVID' named entity 'ibrutinib' named entity 'immunosuppressive' named entity 'CLL' named entity 'ibrutinib' named entity 'ibrutinib' named entity 'Th17' named entity 'azithromycin' named entity 'SARS-CoV-2' named entity 'IL-2' named entity 'hypertension' named entity 'LMWH' named entity 'venetoclax' named entity 'venetoclax' named entity 'granulocytes' named entity 'Ibrutinib' named entity 'COVID' named entity 'CLL' named entity 'ibrutinib' named entity 'FDA' named entity 'IL-6' named entity 'immunomodulatory' named entity 'Btk' named entity 'CRS' named entity 'SARS-CoV-2' named entity 'Idelalisib' named entity 'SARS-CoV-2' named entity 'COVID' named entity 'chronic disease' named entity 'hydroxychloroquine' named entity 'lopinavir/ritonavir' named entity 'IL-6'

Attributes

Values

Creator

Cassin, Ramona
Noto, Alessandro
Reda, Gianluigi
Farina, Lucia
Ghia, Paolo
Scarfò, Lydia
Borella, Chiara
Molteni, Alfredo
Montillo, Marco
Tedeschi, Alessandra
Zamprogna, Giulia

is schema:about of

named entity 'Hospital'
named entity 'hematological'
named entity 'COVID-19'
named entity 'hypertension'
named entity 'SARS-CoV-2'
named entity 'CD8'
named entity 'CLL'
named entity 'CLL'
named entity 'CLL'
named entity 'humoral'
named entity 'Th17 cells'
named entity 'B-cell'
named entity 'COVID-19 infection'
named entity 'COVID'
named entity 'CLL'
named entity 'rituximab'
named entity 'cytokine release syndrome'
named entity 'SARS-CoV-2'
named entity 'COVID'
named entity 'cell-mediated immunity'
named entity '2, 3'
named entity 'ibrutinib'
named entity 'COVID'
named entity 'CD4'
named entity 'Hematology'
named entity 'chemoimmunotherapy'
named entity 'ibrutinib'
named entity 'infectious disease'
named entity 'pulmonary embolism'
named entity 'pneumonia'
named entity 'ibrutinib'
named entity 'Lombardy'
named entity 'Th1/Th2'
named entity 'comorbidities'
named entity 'monocytes'
named entity 'ibrutinib'
named entity 'B-cell'
named entity 'interstitial pneumonia'
named entity 'mortality rates'
named entity 'macrophages'
named entity 'hematological malignancies'
named entity 'clinical trials'
named entity 'Btk'
named entity 'small molecules'
named entity 'CLL'
named entity 'cough'
named entity 'alveolar'
named entity 'evolution'
named entity 'cell-mediated'
named entity 'Th1'
named entity 'ibrutinib'
named entity 'Italian'
named entity 'fever'
named entity 'fludarabine'
named entity 'comorbidities'
named entity 'irreversible inhibitor'
named entity 'CD4'
named entity 'COVID'
named entity 'ibrutinib'
named entity 'immunosuppressive'
named entity 'CLL'
named entity 'ibrutinib'
named entity 'ibrutinib'
named entity 'Th17'
named entity 'azithromycin'
named entity 'SARS-CoV-2'
named entity 'IL-2'
named entity 'hypertension'
named entity 'LMWH'
named entity 'venetoclax'
named entity 'venetoclax'
named entity 'granulocytes'
named entity 'Ibrutinib'
named entity 'COVID'
named entity 'CLL'
named entity 'ibrutinib'
named entity 'FDA'
named entity 'IL-6'
named entity 'immunomodulatory'
named entity 'Btk'
named entity 'CRS'
named entity 'SARS-CoV-2'
named entity 'Idelalisib'
named entity 'SARS-CoV-2'
named entity 'COVID'
named entity 'chronic disease'
named entity 'hydroxychloroquine'
named entity 'lopinavir/ritonavir'
named entity 'IL-6'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software